skip to main content

Gout urate-lowering therapy — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

EasyCrystal arthropathiesGout urate-lowering therapySCE Rheumatology

A 58-year-old man has recurrent podagra and serum urate 560 µmol/L. Symptoms settle with naproxen; he now asks about prevention. eGFR is 72 mL/min/1.73 m^2 and he takes amlodipine. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AStart low-dose allopurinol with flare prophylaxis and titrate to target urate

Recurrent gout warrants urate-lowering therapy, usually allopurinol started low and titrated to a target serum urate, with prophylaxis against mobilisation flares. Diet alone rarely achieves adequate urate lowering. Starting at high dose increases adverse effects and does not follow treat-to-target principles.

Reference: NICE NG219; BSR gout guideline